MPS Pharmaa informs about outcome of board meeting

13 Aug 2024 Evaluate

MPS Pharmaa has informed that pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, the Board of Directors of the Company in its meeting held on Tuesday, 13th August, 2024 at 12:00 pm at the corporate office of the company at 703, Arunachal Building, 19, Barakhamba Road, Connaught Place, New Delhi -110001 and concluded at 01:58 P.M has transacted the following business: 1. Considered and Approved the Standalone Un-audited Financial Results of the Company for the quarter ended 30th June, 2024. 2. Considered and Approved the Limited Review Report for the Un-audited Financial Results of the Company for the quarter ended 30th June, 2024. Further pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, a copy of the aforesaid Un-audited Financial Results for the quarter ended 30th June, 2024 along with Limited Review Report thereon is enclosed.

The above information is a part of company’s filings submitted to BSE.


MPS Pharmaa Share Price

3.03 0.00 (0.00%)
01-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1714.25
Dr. Reddys Lab 1149.75
Cipla 1452.70
Lupin 2009.40
Zydus Lifesciences 891.25
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...